QTTB Q32 BIO INC revenue, earnings and financials
For the quarter ended June 30, 2026, Q32 BIO INC reported revenue of n/a, net income of −$8.95M and diluted EPS of −$0.44; for the fiscal year ended December 2025 revenue was $53.7M.
QTTB annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $53.7M, gross profit n/a, operating income $16.9M, net income $29.8M (margin 55.5%), EPS $2.42
- Fiscal year ended Dec 2024: revenue $0, gross profit n/a, operating income −$66.1M, net income −$47.7M (margin n/a), EPS −$6.58
- Fiscal year ended Dec 2023: revenue −$6.65M, gross profit n/a, operating income −$48.3M, net income −$53.7M (margin 807.4%), EPS −$153.96
- Fiscal year ended Dec 2022: revenue $3.21M, gross profit n/a, operating income −$133M, net income −$5.01M (margin -156.0%), EPS −$0.09
- Fiscal year ended Dec 2021: revenue $34.0M, gross profit n/a, operating income −$95.9M, net income −$95.8M (margin -281.9%), EPS −$1.73
QTTB quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$8.95M, EPS −$0.44
- Quarter ended Mar 31, 2026: revenue n/a, net income −$7.61M, EPS −$0.54
- Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income $57.7M, EPS $4.70
- Quarter ended Sep 30, 2025: revenue n/a, net income −$7.39M, EPS −$0.60
- Quarter ended Jun 30, 2025: revenue n/a, net income −$9.49M, EPS −$0.78
- Quarter ended Mar 31, 2025: revenue n/a, net income −$11.0M, EPS −$0.90
- Quarter ended Dec 31, 2024 (from the annual report): revenue $0 (up 100.0% year over year), net income −$14.2M, EPS $2.63
- Quarter ended Sep 30, 2024: revenue $0 (down 100.0% year over year), net income −$17.6M, EPS −$1.46
- Quarter ended Jun 30, 2024: revenue $0 (down 100.0% year over year), net income −$17.0M, EPS −$1.42
- Quarter ended Mar 31, 2024: revenue $0 (down 100.0% year over year), net income $1.03M, EPS −$6.33
- Quarter ended Dec 31, 2023 (from the annual report): revenue −$14.7M (down 1928.2% year over year), net income −$27.0M, EPS −$76.91
- Quarter ended Sep 30, 2023: revenue $1.86M (up 131.8% year over year), net income −$14.0M, EPS −$40.52
- Quarter ended Jun 30, 2023: revenue $3.21M (up 299.6% year over year), net income −$5.81M, EPS −$16.69
- Quarter ended Mar 31, 2023: revenue $2.95M (up 267.5% year over year), net income −$6.84M, EPS −$19.84
- Quarter ended Dec 31, 2022 (from the annual report): revenue $802K (up 0.0% year over year), net income −$34.3M, EPS −$0.58
- Quarter ended Sep 30, 2022: revenue $802K (down 52.2% year over year), net income −$33.7M, EPS −$0.59
- Quarter ended Jun 30, 2022: revenue $802K (down 63.3% year over year), net income −$29.1M, EPS −$0.51
- Quarter ended Mar 31, 2022: revenue $802K (down 97.3% year over year), net income $92.1M, EPS $1.59
- Quarter ended Dec 31, 2021 (from the annual report): revenue $802K, net income −$33.6M, EPS −$0.63
- Quarter ended Sep 30, 2021: revenue $1.68M, net income −$30.6M, EPS −$0.54
QTTB cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$33.5M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$67.7M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$18.7M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$114M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$110M, share buybacks n/a
QTTB balance sheet
- Jun 30, 2026: cash $106M, total assets $116M, total liabilities $9.96M, shareholders' equity $106M
- Mar 31, 2026: cash $50.8M, total assets $63.7M, total liabilities $17.4M, shareholders' equity $46.3M
- Dec 31, 2025: cash $48.3M, total assets $61.8M, total liabilities $19.8M, shareholders' equity $42.0M
- Sep 30, 2025: cash $49.0M, total assets $57.8M, total liabilities $76.2M, shareholders' equity −$18.4M
- Jun 30, 2025: cash $54.8M, total assets $66.1M, total liabilities $78.4M, shareholders' equity −$12.2M
- Mar 31, 2025: cash $65.5M, total assets $79.1M, total liabilities $83.1M, shareholders' equity −$4.01M
- Dec 31, 2024: cash $78.0M, total assets $92.3M, total liabilities $86.7M, shareholders' equity $5.68M
- Sep 30, 2024: cash $89.1M, total assets $105M, total liabilities $86.2M, shareholders' equity $18.3M
What is QTTB's revenue?
Q32 BIO INC reported $53.7M of revenue for the fiscal year ended December 2025.
Is QTTB profitable?
Yes. Q32 BIO INC earned $33.8M over the last four quarters.
What is QTTB's EPS?
Diluted earnings per share over the last four quarters were $3.12; −$0.44 in the latest quarter.